IT1226144B - Di estere fosforico dell'acido ursodeossicolico e suoi derivati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principi attivi. - Google Patents
Di estere fosforico dell'acido ursodeossicolico e suoi derivati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principi attivi.Info
- Publication number
- IT1226144B IT1226144B IT8821189A IT2118988A IT1226144B IT 1226144 B IT1226144 B IT 1226144B IT 8821189 A IT8821189 A IT 8821189A IT 2118988 A IT2118988 A IT 2118988A IT 1226144 B IT1226144 B IT 1226144B
- Authority
- IT
- Italy
- Prior art keywords
- phosphoric
- derivatives
- ester
- ursodeoxycholic acid
- contain
- Prior art date
Links
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 title abstract 2
- 150000005690 diesters Chemical class 0.000 title abstract 2
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 title abstract 2
- 229960001661 ursodiol Drugs 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 alkaline-earths Chemical class 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 150000001414 amino alcohols Chemical class 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000001883 cholelithiasis Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000001130 gallstones Diseases 0.000 abstract 1
- 150000002337 glycosamines Chemical class 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Landscapes
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8821189A IT1226144B (it) | 1988-07-01 | 1988-07-01 | Di estere fosforico dell'acido ursodeossicolico e suoi derivati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principi attivi. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8821189A IT1226144B (it) | 1988-07-01 | 1988-07-01 | Di estere fosforico dell'acido ursodeossicolico e suoi derivati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principi attivi. |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8821189A0 IT8821189A0 (it) | 1988-07-01 |
IT1226144B true IT1226144B (it) | 1990-12-19 |
Family
ID=11178119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT8821189A IT1226144B (it) | 1988-07-01 | 1988-07-01 | Di estere fosforico dell'acido ursodeossicolico e suoi derivati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principi attivi. |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1226144B (it) |
-
1988
- 1988-07-01 IT IT8821189A patent/IT1226144B/it active
Also Published As
Publication number | Publication date |
---|---|
IT8821189A0 (it) | 1988-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK72287A (en) | Orally administrable antidiabetic compositions | |
ZA894728B (en) | A new pharmaceutical formulation as well as a process for its preparation | |
IL86782A0 (en) | Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions comprising the same | |
AU3955089A (en) | Pharmaceutical composition comprising protein kinase c inhibitor and anti-cancer agent | |
CA2127352A1 (en) | Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it | |
AU563642B2 (en) | Oral antidiabetic composition | |
IL87936A0 (en) | Polysulfuric acid esters of bis-aldonamides and their derivatives,the preparation and pharmaceutical compositions containing them | |
AU4846690A (en) | Polyunsaturated fatty acid derivatives, pharmaceutical compositions containing the same, method for the preparation thereof, and their use as medicament | |
HUT50112A (en) | Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component | |
ZA884622B (en) | Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance | |
HUT47233A (en) | Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients | |
JPS56110679A (en) | 55aminootetrazole derivative of retinoic acid* its manufacture and medicine containing it | |
AU536582B2 (en) | Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends | |
IT1226144B (it) | Di estere fosforico dell'acido ursodeossicolico e suoi derivati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principi attivi. | |
HUT47077A (en) | Process for producing hydrocinnamomic acid derivatives and pharmaceutical compositions containing them as active components | |
AU532982B2 (en) | Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2- carboxylic acid esters | |
HUT61561A (en) | Process for producing octadecyl-/2-(n-methylpiperidino)-ethyl/-phosphate and pharmaceutical compositions comprising same as active ingredient | |
DE3065087D1 (en) | Piperidine derivatives of 3-hydroxy-thiophene-2-carboxylic acid esters, their preparation, and pharmaceutical preparations containing them | |
HUT49054A (en) | Process for producing pharmaceutical compositions absorbed through the derm and comprising pyrazolo(1,5-a) pyridine derivatives as active ingredient | |
ZA824649B (en) | New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds | |
EP0389773A3 (de) | Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO) | |
AU2506188A (en) | Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance |